loading
Schlusskurs vom Vortag:
$12.84
Offen:
$12.77
24-Stunden-Volumen:
973.67K
Relative Volume:
0.83
Marktkapitalisierung:
$647.68M
Einnahmen:
$1.02B
Nettoeinkommen (Verlust:
$-757.20M
KGV:
-0.8287
EPS:
-14.76
Netto-Cashflow:
$-257.90M
1W Leistung:
+23.73%
1M Leistung:
+36.63%
6M Leistung:
+125.68%
1J Leistung:
+33.02%
1-Tages-Spanne:
Value
$11.74
$13.00
1-Wochen-Bereich:
Value
$9.21
$13.41
52-Wochen-Spanne:
Value
$4.02
$13.41

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
Firmenname
Emergent Biosolutions Inc
Name
Telefon
240-631-3200
Name
Adresse
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
Mitarbeiter
900
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
EBS's Discussions on Twitter

Vergleichen Sie EBS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
12.14 676.67M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.02 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.43 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.245 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.09 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
448.03 19.53B 3.08B 1.24B 1.07B 25.61

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-30 Eingeleitet H.C. Wainwright Buy
2024-08-22 Eingeleitet Rodman & Renshaw Buy
2024-03-07 Hochstufung The Benchmark Company Hold → Buy
2023-11-20 Fortgesetzt JP Morgan Underweight
2023-08-29 Herabstufung The Benchmark Company Buy → Hold
2023-04-10 Hochstufung The Benchmark Company Hold → Buy
2023-03-17 Herabstufung JP Morgan Neutral → Underweight
2022-11-10 Herabstufung The Benchmark Company Buy → Hold
2022-04-29 Herabstufung Cantor Fitzgerald Overweight → Neutral
2022-01-20 Hochstufung The Benchmark Company Hold → Buy
2021-11-08 Herabstufung The Benchmark Company Buy → Hold
2021-05-05 Herabstufung Argus Buy → Hold
2021-04-07 Eingeleitet The Benchmark Company Buy
2021-02-24 Hochstufung Chardan Capital Markets Neutral → Buy
2021-02-19 Herabstufung Chardan Capital Markets Buy → Neutral
2021-01-08 Herabstufung Wells Fargo Overweight → Equal Weight
2020-09-14 Fortgesetzt JP Morgan Neutral
2020-07-31 Bestätigt Chardan Capital Markets Buy
2019-09-12 Eingeleitet Guggenheim Buy
2019-09-04 Hochstufung Wells Fargo Market Perform → Outperform
2018-11-02 Hochstufung Goldman Neutral → Buy
2018-08-03 Bestätigt Chardan Capital Markets Buy
2018-06-13 Eingeleitet Argus Buy
2018-04-25 Herabstufung Wells Fargo Outperform → Market Perform
2018-01-24 Eingeleitet Goldman Neutral
2018-01-16 Bestätigt Chardan Capital Markets Buy
2016-06-28 Bestätigt Singular Research Buy
2016-04-15 Eingeleitet Chardan Capital Markets Buy
2016-03-28 Eingeleitet Singular Research Buy
2016-02-19 Eingeleitet Wells Fargo Outperform
2014-05-15 Eingeleitet Summer Street Research Buy
2011-05-31 Bestätigt WBB Securities Strong Buy
2011-01-10 Bestätigt Wedbush Outperform
2010-11-05 Bestätigt Wedbush Outperform
2010-08-18 Hochstufung WBB Securities Buy → Strong Buy
2010-08-06 Bestätigt Caris & Company Buy
Alle ansehen

Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten

pulisher
06:02 AM

Is Emergent BioSolutions Inc. stock dividend yield sustainableJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com

06:02 AM
pulisher
05:24 AM

What sentiment indicators say about Emergent BioSolutions Inc. stock2025 Volume Leaders & Reliable Entry Point Alerts - newser.com

05:24 AM
pulisher
03:14 AM

symbol__ Stock Quote Price and Forecast - CNN

03:14 AM
pulisher
01:32 AM

How Emergent BioSolutions Inc. stock benefits from tech adoptionJuly 2025 Momentum & Verified Momentum Watchlists - newser.com

01:32 AM
pulisher
01:24 AM

Why Emergent BioSolutions Inc. (ER4) stock is trending on social media2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com

01:24 AM
pulisher
01:06 AM

Emergent BioSolutions Reports Strong Q3 2025 Results - The Globe and Mail

01:06 AM
pulisher
01:05 AM

Why Emergent BioSolutions Inc. (ER4) stock is listed among top recommendations2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com

01:05 AM
pulisher
12:34 PM

Will Emergent BioSolutions Inc. stock return to pre crisis levelsPortfolio Update Report & Stepwise Trade Signal Guides - newser.com

12:34 PM
pulisher
Oct 30, 2025

Emergent Biosolutions (NYSE:EBS) Issues Quarterly Earnings Results, Beats Expectations By $1.18 EPS - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent BioSolutions Inc (EBS) Q3 2025 Earnings Call Highlights: Surpassing Revenue ... By GuruFocus - Investing.com Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent BioSolutions (EBS) Earnings Transcript - The Globe and Mail

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent BioSolutions Inc (EBS) Q3 2025 Earnings Call Highlights: Surpassing Revenue ... - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent BioSolutions raises 2025 guidance to $835M revenue and $210M EBITDA as international MCM sales surge - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Gaithersburg-based Emergent Biosolutions reports Q3 earnings - Maryland Daily Record

Oct 30, 2025
pulisher
Oct 30, 2025

Analyzing Emergent BioSolutions Inc. with multi timeframe chartsQuarterly Trade Summary & Fast Moving Stock Watchlists - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Emergent BioSolutions Inc. benefit from macro trendsBull Run & Reliable Volume Spike Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Emergent BioSolutions Inc. stock sustain high P E ratiosJuly 2025 Gainers & Precise Buy Zone Identification - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Why Emergent BioSolutions Inc. (ER4) stock remains top ratedMarket Growth Summary & Verified Entry Point Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent Biosolutions: Q3 Earnings Snapshot - Stamford Advocate

Oct 30, 2025
pulisher
Oct 30, 2025

Understanding Emergent BioSolutions Inc.’s price movementWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will breakout in Emergent BioSolutions Inc. lead to full recoveryEarnings Recap Report & Technical Analysis for Trade Confirmation - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Why millennials buy Emergent BioSolutions Inc. (ER4) stockShort Setup & Real-Time Chart Breakout Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Reversal indicators forming on Emergent BioSolutions Inc. stockJuly 2025 Update & Safe Entry Zone Identification - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Is Emergent BioSolutions Inc. a candidate for recovery playGlobal Markets & Community Trade Idea Sharing Platform - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent Biosolutions earnings beat by $1.01, revenue topped estimates - Investing.com Canada

Oct 29, 2025
pulisher
Oct 29, 2025

Why Emergent BioSolutions Inc. stock remains resilientJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates - sharewise.com

Oct 29, 2025
pulisher
Oct 29, 2025

EBS Boosts Financial Outlook for Fiscal Year - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Inc Bottom Line Drops In Q3 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Raises Full-Year Revenue Guidance - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Inc Reports Q3 2025 Earnings: EPS of $0.91 - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Q3 revenue beats guidance, raises full-year outlook - TradingView

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Reports Third Quarter 2025 Financial Results - The Manila Times

Oct 29, 2025
pulisher
Oct 29, 2025

How Emergent BioSolutions Inc. (ER4) stock behaves in tightening cyclesJuly 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Investors in Emergent BioSolutions (NYSE:EBS) have unfortunately lost 90% over the last five years - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Chart based exit strategy for Emergent BioSolutions Inc.Watch List & High Accuracy Investment Entry Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why Emergent BioSolutions Inc. stock could rally in 20252025 Short Interest & Growth Oriented Trading Recommendations - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Emergent Biosolutions Q3 earnings call set to reveal financial results - Traders Union

Oct 28, 2025
pulisher
Oct 28, 2025

Retail Traders Turn Ultra-Bullish On Emergent BioSolutions After Surprise Q3 Profit - Stocktwits

Oct 28, 2025
pulisher
Oct 28, 2025

Emergent (NYSE: EBS): 45% say U.S. unprepared, 65% see rising bioattack risk - Stock Titan

Oct 28, 2025

Finanzdaten der Emergent Biosolutions Inc-Aktie (EBS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$46.62
price up icon 5.78%
drug_manufacturers_specialty_generic RDY
$13.32
price down icon 1.00%
$22.70
price up icon 0.55%
$10.38
price up icon 0.25%
$140.26
price up icon 1.07%
$448.03
price down icon 1.21%
Kapitalisierung:     |  Volumen (24h):